An Evaluation of costs borne by TB-affected Households in Rwanda

Principal investigator: Migambi Patrick
Check PI profile

Investigators

Patrick Migambi, Felix Murego, Stella Matutina Umuhoza, Augustin Dushime, Pacifique Ndishimye, Propser Karame, Yves Mucyo, Jean Baptiste Byiringiro, Sedona Sweeney

Study information

  • Research Area: Tuberculosis
  • Research type: Cross-sectional
  • Start date: Oct 01, 2020
  • End date: Dec 31, 2021

Study aim of the objectives

[1] To document the magnitude and main drivers of different type of costs incurred by TB Patients ( and their households) in order to guide policies to reduce financial access barriers and minimize the adverse socio-economic impact of TB

[2] To determine the baseline and periodically measure the percentage of TB patients ( and their households) treated in the NTP network and incurring catastrophic total costs due to TB

Study setting/Area (Location)

Countrywide-Health facility based survey

Implementing institution

Rwanda Biomedical Centre, UR and WHO

Department/Division

TB&ORD

Impact on Policy

Evidence current TB related cost and needs for cost readjustment to improve TB treatment outcome

Study implementation progress

Related research

Login
Support